1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Dezhan Healthcare Company Limited

Dezhan Healthcare Company Limited

000813.SZ
Dezhan Healthcare Company LimitedCN flagShenzhen Stock Exchange
3.24
CNY
+0.05
- -
6.79BMarket Cap

Total Valuation

Dezhan Healthcare Company Limited carries a market capitalization of 6.79B, placing it among publicly traded companies globally. Its enterprise value stands at 6.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.79B
Enterprise Value6.03B

Share Statistics

Dezhan Healthcare Company Limited currently has 2.10B shares outstanding.

Shares Outstanding2.10B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 25.92, and the price-to-book ratio stands at 1.70.

PE RatioN/A
PS Ratio25.92
PB Ratio1.70
P/TBV Ratio1.79
P/FCF Ratio33.27
P/OCF RatioN/A

Enterprise Valuation

EV / Sales21.17
EV / EBITDAN/A
EV / EBITN/A
EV / FCF26.97

Financial Position

Dezhan Healthcare Company Limited maintains a current ratio of 16.69, meaning it holds 16.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.93, indicating elevated leverage, while an interest coverage ratio of -93.18 demonstrates limited ability to service its debt obligations.

Current Ratio16.69
Quick Ratio10.88
Debt / Equity2.93
Debt / EBITDA-0.82
Interest Coverage-93.18

Financial Efficiency

Return on Equity (ROE)-7.47
Return on Assets (ROA)-6.69
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.82

Taxes

Income Tax-5.50M
Effective Tax RateN/A

Stock Price Statistics

Dezhan Healthcare Company Limited's stock has declined approximately -3.85757% over the past 52 weeks. The 50-day moving average sits at 3.40, while the 200-day moving average is 3.81.

Beta (5Y)N/A
52-Week Price Change-3.85757%
50-Day Moving Average3.40
200-Day Moving Average3.81
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Dezhan Healthcare Company Limited generated 285.01M in revenue and converted that into -339.63M in net income, yielding earnings per share of -0.19. EBITDA reached -161.59M, while operating income came in at -161.59M.

Revenue285.01M
Gross Profit145.02M
Operating Income-161.59M
Pretax Income-412.55M
Net Income-339.63M
EBITDA-161.59M
EBIT-161.59M
Earnings Per Share (EPS)-0.19

Balance Sheet

Dezhan Healthcare Company Limited holds 1.42B in cash and equivalents against 132.91M in total debt, resulting in a net debt position of -1.30B. Total book value stands at 4.33B, with working capital of 2.04B providing operational flexibility.

Cash & Cash Equivalents1.42B
Total Debt132.91M
Net Debt-1.30B
Equity (Book Value)4.33B
Book Value Per Share2.07
Working Capital2.04B

Cash Flow

After subtracting -222.05M in capital expenditures, free cash flow totaled -222.05M - equivalent to -0.11 per share.

Operating Cash FlowN/A
Capital Expenditures-222.05M
Free Cash Flow-222.05M
FCF Per Share-0.11

Margins

Dezhan Healthcare Company Limited operates with a gross margin of 50.88, reflecting its pricing power and cost economics. The operating margin of -56.70 and net profit margin of -119.16 provide insight into operational efficiency.

Gross Margin50.88
Operating Margin-56.70
Pretax Margin-144.75
Profit Margin-119.16
EBITDA Margin-56.70

Dividends & Yields

The company's payout ratio of -0.30 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.00
Dividend YieldN/A
Payout Ratio-0.30
Shareholder Yield0.56
FCF Yield3.01

Stock Splits

Dezhan Healthcare Company Limited's most recent stock split took place on May 24, 2017 with a 2:3 split ratio.

Last Split Date5/24/2017
Split Ratio2:3

Scores

Dezhan Healthcare Company Limited posts an Altman Z-Score of 17.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score17.94